PET-CT, Bio-imaging for Predicting Prognosis and Response to Chemotherapy in Patients with Lung Cancer
Publisher
Springer Singapore
Reference63 articles.
1. Sasaki R, Komaki R, Macapinlac H et al (2005) [18F] fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol 23:1136–1143
2. Vansteenkiste JF, Stroobants SG, Dupont PJ et al (1999) Prognostic importance of the standardized uptake value on 18F-fluoro-2-deoxy-glucose-positron emission tomography in non-small cell lung cancer: an analysis of 125 cases. J Clin Oncol 17:3201–3206
3. Berghmans T, Dusart M, Paesmans M et al (2008) Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European lung cancer working party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 3:6–12
4. Kaira K, Endo M, Abe M et al (2010) Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors. J Clin Oncol 28:3746–3753
5. Kaira K, Serizawa M, Koh Y et al (2014) Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer. Lung Cancer 83:197–204